BCG failure is much less common than previously thought in non-muscle invasive bladder cancer, so is adding a checkpoint ...

Survival rates from small trial suggest that adding pazopanib to standard treatment for Ewing sarcoma in children may extend lives without adding severe toxicity.

Adding immunotherapy to chemotherapy can improve survival in patients with metastatic, poorly differentiated GEP-NECs, data suggest.

Cardiff Oncology (CRDF) is a speculative buy with potential blockbuster gains ahead of its 2026 data readout. Read here for ...

Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists ...

BERLIN -- The investigational tyrosine kinase inhibitor (TKI) zanzalintinib plus atezolizumab (Tecentriq) significantly ...

Caremark unit delays adding the company's new HIV prevention drug Yeztugo over pricing concerns. Read more here.

A novel combination therapy pairing a DNA-synthesis inhibitor with a targeted radiopharmaceutical may improve outcomes for ...

The monarchE trial's primary overall survival (OS) analysis presented at ESMO 2025 confirms that 2 years of ...

In the current study, the association between mRNA COVID vaccination and survival was strongest among patients whose tumors ...

Iams, MD, MSCI, examined outcomes of the phase 3 IMforte trial in extensive-stage small cell lung cancer. Adding immunotherapy to platinum-based chemotherapy is an established standard of care for ...

New research presented this year highlighted major advances for people with hormone-receptor–positive, HER2-negative breast ...